In a 92 page presentation there is only one small bullet point on GCL, with absolutely no further explanation????Hope somebody asks some hard qu's at the AGM and can report back here.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%